Skip to content

Ginkgo Bioworks DNA Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Operating margin-210.7%-7.1pp-192%+54.6pp-199.5%+91.5pp-138.3%+331pp-203.5%+193pp
Net margin-215.4%-7.7pp-195.4%+45.5pp-199.1%+99.7pp-142.8%+344pp-207.7%+201pp
Returns
Return on equity-55.8%+1.9pp-51.1%+9.3pp-50%+13.5pp-43.6%+33.2pp-57.8%+8.1pp
Return on invested capital-42.8%+44.4pp-46.8%+73.9pp-48.3%+62.6pp-57%+112pp-87.2%+64.8pp
Efficiency
Asset turnover0.1×0.0×0.1×0.0×0.1×0.0×0.2×+0.1×0.2×+0.1×
Liquidity
Current ratio5.2×+0.3×4.9×-0.7×4.4×-1.4×5.4×+0.7×4.9×-0.5×
Leverage
Debt-to-equity0.9×+0.3×0.9×+0.2×0.8×+0.2×0.7×+0.4×0.7×+0.4×
Valuation
Market capitalization$625.16M+24.6%$503.5M-10.8%$863.13M+90.6%$537.91M-27.2%$330.79M-86.8%
Price / sales4.4×+2.2×3.1×+0.7×5.1×+3.0×2.4×-1.6×1.5×-10.5×
Price / book1.4×+0.6×+0.2×1.5×+1.0×0.9×0.0×0.5×-2.0×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Ginkgo Bioworks's ratios come from?
Every ratio is computed from Ginkgo Bioworks's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.